Semaglutide vs. Tirzepitide: Which Obesity Drug Could Be Your Game Changer Part 1

The Plus SideZ: Cracking the Obesity Code

Resources for the Community:
____________________________________________________________________________________________
https://linktr.ee/theplussidezpodcast 

Ro - Telehealth for GLP1 weight management 

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
____________________________________________________________________________________________
Part 1
This episode delves into the intricate relationship between insulin resistance, polycystic ovarian syndrome (PCOS), and obesity. We explore how these conditions often intertwine, leading to a cyclical pattern that can be challenging to break.

We discuss the fascinating study of adipose tissue's remarkable ability to remember past weight gain, even after significant weight loss. This phenomenon sheds light on the persistent challenges faced by individuals who have lost weight and are striving to maintain their progress.

We also delve into the critical role of basal metabolic rate (BMR) and caloric consumption in weight management. Understanding these factors can empower individuals to make informed choices about their diet and exercise routines.

Finally, we compare and contrast two groundbreaking medications, semaglutide and tirzepitide. Both drugs have shown remarkable efficacy in treating obesity, but there are key differences in their mechanisms of action and potential side effects. We explore the latest research to determine which medication may be the best fit for different individuals.
____________________________________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF
____________________________________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez
______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy 

Support the show

Kim Carlos, Executive Producer

TikTok

https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr

Kat Carter, Associate Producer

TikTok

https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

若要收听包含儿童不宜内容的单集,请登录。

关注此节目的最新内容

登录或注册,以关注节目、存储单集,并获取最新更新。

选择国家或地区

非洲、中东和印度

亚太地区

欧洲

拉丁美洲和加勒比海地区

美国和加拿大